501
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Overview of alemtuzumab therapy for the treatment of T-cell lymphomas

, , , , , , , & show all
Pages 789-795 | Received 01 Aug 2011, Accepted 02 Oct 2011, Published online: 18 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, Mitchell P Levesque, Reinhard Dummer & Antonio Cozzio. (2014) Novel therapies for cutaneous T-cell lymphoma: what does the future hold?. Expert Opinion on Investigational Drugs 23:4, pages 457-467.
Read now

Articles from other publishers (11)

Miguel Nogueira, Catarina Lau, Maria dos Anjos Teixeira, Rita Peixeiro, Renata Cabral & Iolanda Fernandes. (2023) Alemtuzumab as first‐ and second‐line treatment in patients with Sézary syndrome—The experience of a tertiary centre. Journal of the European Academy of Dermatology and Venereology.
Crossref
Floris C. Loeff, Kevin Rijs, Esther H. M. van Egmond, Willem H. Zoutman, Xiaohang Qiao, Wilhelmina G. M. Kroes, Sabrina A. J. Veld, Marieke Griffioen, Maarten H. Vermeer, Jacques Neefjes, J. H. Frederik Falkenburg, Constantijn J. M. Halkes & Inge Jedema. (2018) Loss of the GPI‐anchor in B‐lymphoblastic leukemia by epigenetic downregulation of PIGH expression . American Journal of Hematology 94:1, pages 93-102.
Crossref
Thomas A. Rasmussen, James McMahon, J. Judy Chang, Jori Symons, Michael Roche, Ashanti Dantanarayana, Afam Okoye, Bonnie Hiener, Sarah Palmer, Wen Shi Lee, Stephen J. Kent, Carrie Van Der Weyden, H. Miles Prince, Paul U. Cameron & Sharon R. Lewin. (2017) Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS 31:13, pages 1839-1845.
Crossref
Kerry Heitmiller, Jeffrey Barnes & Steven T. Chen. (2017) Cutaneous Lymphoma—Inpatient Considerations. Current Dermatology Reports 6:2, pages 63-76.
Crossref
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi & Stefano Pileri. (2016) Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas. Critical Reviews in Oncology/Hematology 99, pages 228-240.
Crossref
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi & Stefano Pileri. (2016) Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas. Critical Reviews in Oncology/Hematology 99, pages 214-227.
Crossref
Jun-ichi Masuyama, Takashi Murakami, Sanju Iwamoto & Sanehiko Fujita. (2016) Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies. Cytotherapy 18:1, pages 80-90.
Crossref
Jonathan Hebb & Holbrook Kohrt. (2015) Targets, Toxins, and T Cells—a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas. Current Hematologic Malignancy Reports 10:4, pages 438-447.
Crossref
Kristy L. Richards & Steven E. Suter. (2014) Man's best friend: what can pet dogs teach us about non‐ H odgkin's lymphoma? . Immunological Reviews 263:1, pages 173-191.
Crossref
Lionel Karlin & Bertrand Coiffier. (2014) The Changing Landscape of Peripheral T-Cell Lymphoma in the Era of Novel Therapies. Seminars in Hematology 51:1, pages 25-34.
Crossref
E. Jolanda Münzel & Anna Williams. (2013) Promoting Remyelination in Multiple Sclerosis—Recent Advances. Drugs 73:18, pages 2017-2029.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.